1st ESDO - BGDO MASTERCLASS: INNOVATION IN GI CANCERS Oct 6 - 7, 2017

Slides:

Advertisements

Similar presentations

, Eelen S. MA 1, Bauwens S. MA 2, Distelmans W. MD PhD 2, Hensmans B. MSc 3, Schrauwen W. MA 4, Vanderlinden L. MA 4, Verzelen A. MA 5, Mathys R. MD 1.

Advertisements

Implementaton of the new EU Directive 2010/63/EU On the protection of animals used for scientific purposes: Opportunities for the 3Rs Berlin. January 31-February.

CPT Review of Drug Administration Services AMA Presentation.

1 Billion (WHO 2003) 1 Billion (WHO 2003). Functional nutrition? Health Disease Health Nutrition in the process of care.

Visit the ISTH Online The mission of the International Society on Thrombosis and Haemostasis (ISTH) is to advance the understanding, prevention,

UEMS Section of Gastroenterology Workhop BASL Proposals for Hepatology Training P. Michielsen Brussels, Nov. 29, 2000.

11 th CMC Vellore Scientific Symposium on Endocrine Tumours July 4 th —6 th, 2013 (Thursday to Saturday) Venue: Scudder Auditorium, Christian Medical College,

AMERICAN COLLEGE OF RADIOLOGY March 23, OUR MISSION To foster the ongoing development of widely acceptable consistent imaging.

Early Clinical Study in Cancer Patients Paris Region Paris 22, 23 February 2007.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

The Bologna Declaration and its implementation at Katholieke Universiteit Leuven (Belgium) JEP UM Zagreb, 28 October 2004 An Huts International.

Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.

Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.

THE 18 TH ENOTHE GENERAL ASSEMBLY MEETING, FRIDAY 19 TH OCTOBER 2012 VENUE: LITEXPO, VILNIUS, LITHUANIA President/Chairperson of GA: Anne Lawson-Porter.

Mainz - Germany. Dear Friends and Colleagues, It is our great pleasure to invite you to the autumn meeting of the “EORTC- Gastrointestinal Tract Cancer.

Technology and Innovation Development Award (TIDA) Presenter Dr Michael Ryan SFI.

Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.

Allocation of funding at Ghent University. Luc François Director Ghent University Association 2 Ghent University 1. Founded in 1817 by William I, King.

OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.

Multipartite “College Nuclear Medicine” (Founded in October 2004) A) General aim: “Role of Nuclear Medicine (Molecular) Imaging in Evidence Based Medicine”

Promotions on the Clinician Educator Track Larry L. Swift, Ph.D. Vice Chair for Faculty Affairs Department of Pathology, Microbiology & Immunology.

Amsterdam RAI EACCME applied Register online at Inflammatory Bowel Diseases 2016 IBD innovations driving clinical decisions.

Renato Piantanida Chairman Dept. of Otorhinolaryngology Ospedale A. Manzoni Lecco TREASURY REPORT October 2014.

New Delhi, March, 2007 EuroIndiaNet: Platform Implementation Plan Tiju Joseph, The Institute of Nanotechnology, UK.

United States Public Health Service -National Clinical Pharmacy Specialist (NCPS) Presentation prepared Presentation prepared by: CDR Anne Marie.

Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.

Why invest in Young Medical Oncologists? Fortunato Ciardiello ESMO President-Elect & Young Oncologists Committee Mentor.

Supported by Eli Lilly and Company. Eli Lilly and Company has not influenced the content of this publication GI SLIDE DECK 2015 Selected abstracts from:

Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.

A 20-year success story: The Canada Foundation for Innovation the transformational impacts of sustained investments in research infrastructure Expanding.

Main topics Who are we at EMA and what is our regulatory experience in Parkinson’s disease (PD) Initiatives available at EMA to stimulate and support.

Multipartite “College Nuclear Medicine” (Founded in October 2004)

What is the ACGS? What does the ACGS do?

Inflammatory Bowel Diseases 2017 Advancing knowledge, improving care

Next Generation Reimbursement: regulation in times of fast evolution

CULTURAL PERFORMANCES

Support- IRDiRC Proposed Work Plan And Communication Strategy

REPORTING SDG INDICATORS USING NATIONAL REPORTING PLATFORMS

Funding Opportunities at Ministry of Science, Research & Technology (MSRT) Oct Tehran, I. R. Iran.

Upgrading the research performance in molecular medicine at the

Better Science, Better Health: New Healthcare Models

From Friday September 4th to Saturday September 12th, 2009

9 – 10 October Vibrant Manchester, the Original Modern City, is one of the most exciting places to visit in the UK and the ideal.

International cooperation in Health

Action: BM0806 Recent Advances in Histamine Receptor H4R Research

OMICS Journals are welcoming Submissions

UEMS council meetings October 2016 and April 2017

The European Group of the International Society for Apheresis (ISFA)

New Agent Professional Development

Cancer Stem Cell Therapies in Gastrointestinal Cancers

Learning Objectives. A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology.

6th EULAR Epidemiology Course 2018

Nina Axelrad Lecture CTOS November 2005

THE EUROPEAN UMBRELLA ORGANISATION FOR GEOGRAPHIC INFORMATION

First International Medical Device Compliance Congress

2017 ESR survey on research in imaging in Europe

National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current Cases of Gastrointestinal Cancer Friday, January 21, :00.

AWARENESS ACTIONS ON PANCREATIC CANCER IN FRANCE

CanMEDS Roles Covered X

Precision Medicine A New Era Hazem Assi American University of Beirut

Cancer Symptom Trials (CST) Membership

COST and COST Actions Participation of Georgian researchers

BDHP Cancer Theme Seminar Haematology Cancers

CanMEDS Roles Covered X

Cancer Symptom Trials (CST) Membership

Euler-Venn diagram showing concordance of MTB decision with OncoKB recommendations for molecular driven targeted therapy; comparison of (A) MTB and ttNGS.

CanMEDS Roles Covered X

Presentation transcript:

1st ESDO - BGDO MASTERCLASS: INNOVATION IN GI CANCERS Oct 6 - 7, 2017 IRISH COLLEGE LEUVEN, BELGIUM Online registration is open http://bit.ly/participant_MC2017 During two days, renowned European experts teach on the latest multidisciplinary innovations in Gastrointestinal Cancer at the 1st ESDO-BGDO MASTERCLASS organized in collaboration between the European Society of Digestive Oncology and the Belgian Group of Digestive Oncology. Details: www.esdo.eu/education/esdo-master-class Scientific Committee: Eric Van Cutsem ESDO President / Belgium Thomas Seufferlein ESDO Secretary General / Germany Ivan Borbath BGDO President / Belgium Jean-Luc Van Laethem ESDO Education Chair / Belgium Faculty includes: Pierre Coulie, Belgium / Christophe De Roose, Belgium / Ulrich Güller, Switzerland / Pierre Laurent-Puig, France / Côme Lepage, France / Murielle Mauer (EORTC), Belgium / Markus Möhler, Germany / Wolff Schmiegel, Germany / Max Seidensticker, Germany / Sabine Tejpar, Belgium / Aziz Zaanan, France Interested physicians are welcome to submit a CV to ESDO office info@esdo.eu Limited capacity for 60 persons Applications considered on a first-come first-serve basis. ESDO provides accommodation and boarding and covers international travel expenses up to € 250. Registration fee: 75 € ESDO & BGDO members (105 € non-members)

FRIDAY October 6, 2017 PROGRAMME Advances in Immuno-Oncology in GI Cancer Understanding immune mechanisms in cancer and how to interfere? Clinical trials in GI cancer Design and interpretation of trials: hurdles, requirements and condition (round table) Statistics for the Clinicians General principles Innovative design of trials in the era of targeted agents Clinical Relevance of Molecular Taxonomy in GI Cancer Unraveling CRC Pancreatic cancer Gastric cancer Technology Platforms for Molecular Drugs: how to apply this in clinical practise Clinical relevance of NGS Liquid biopsies Determining resistance and response to new drugs SATURDAY October 7, 2017 Functional imaging in GI cancer Functional imaging: the role of Ultrasonography Functional MRI PET/CT and PET/MRI MRI in rectal cancer Response evaluation after loco-regional therapy Organization: Liz Tanzer info@esdo.eu ww.esdo.eu tel. +43 676 7076079 Onsite Organization: Anne-Sophie Wirtz www.bgdo.org management@bgdo.org tel. + 32 476 312 411